Chemoinformaics analysis of Dihydroisoalantolactone
| Molecular Weight | 234.339 | nRot | 0 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 17 |
| Exact Molecular Weight | 234.162 | nRing | 3 |
| Solubility: LogS | -4.242 | nHRing | 1 |
| Solubility: LogP | 3.652 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 41.3234 |
| nHD | 0 | BPOL | 24.6746 |
| QED | 0.475 |
| Synth | 4.238 |
| Natural Product Likeliness | 2.894 |
| NR-PPAR-gamma | 0.013 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.662 |
| MDCK | 0.0000347 |
| BBB | 0.345 |
| PPB | 0.790944 |
| VDSS | 1.188 |
| FU | 0.256984 |
| CYP1A2-inh | 0.193 |
| CYP1A2-sub | 0.373 |
| CYP2c19-inh | 0.188 |
| CYP2c19-sub | 0.802 |
| CYP2c9-inh | 0.207 |
| CYP2c9-sub | 0.266 |
| CYP2d6-inh | 0.016 |
| CYP2d6-sub | 0.465 |
| CYP3a4-inh | 0.755 |
| CYP3a4-sub | 0.377 |
| CL | 3.689 |
| T12 | 0.206 |
| hERG | 0.04 |
| Ames | 0.034 |
| ROA | 0.11 |
| SkinSen | 0.189 |
| Carcinogencity | 0.135 |
| EI | 0.642 |
| Respiratory | 0.867 |
| NR-Aromatase | 0.647 |
| Antiviral | Yes |
| Prediction | 0.886859 |